The Medical Devices Sector at the Saudi Food and Drug Authority is responsible for ensuring the safety, efficacy, and performance of medical devices under comprehensive legislation and regulation. The sector is aligned with international practices, chairing the Global Harmonization Working Party (GHWP), and actively participating in technical committees in IMDRF and ISO.
The regulation covers the entire lifecycle of medical devices, from idea to end-users, and monitors their performance and safe use. The sector performs regulatory activities such as reviewing technical files, clinical trials, post-market surveillance plans, and quality documents before granting marketing authorization. It also monitors approved devices using a risk-based approach, analyzes field safety notices, adverse events, and safety signals, and communicates effectively with healthcare providers.
The sector also oversees medical radiation emitting devices, medical radioactive material, and radiation protection at healthcare providers, ensuring compliance with SFDA regulatory requirements.
The sector manages a unique centre with the World Health Organization (Saudi FDA WHO-Collaboration Centre), providing international services in training, workshops, and active participation of SFDA experts.
Means any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material or other similar or related
A. Intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the specific purposes(s) of:
-Diagnosis, prevention, monitoring, treatment, or alleviation of disease,
-Diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap,
-Investigation, replacement, modification, or support of the anatomy or of a physiological process,
-Supporting or sustaining life,
-Control of conception,
-Disinfection of medical devices,
-Providing information for medical or diagnostic purposes by means of in vitro examination of specimens derived from the human body; and
B. which does not achieve its primary intended action in or on the human body by pharmacological, immunological, or metabolic means, but which may be assisted in its intended function by such means.
Class |
Risk | Example |
Class A |
Low |
Wound dressings, such as: Absorbent pads, Island dressings |
Class A – supplied sterile |
Low-medium | Personal protection kits |
Class A – incorporating a measuring function |
Low-medium |
Stethoscope |
Class A – reusable surgical instruments |
Low-medium |
Scalpels and scalpel handles, reamers, drill bits, scissors |
Class B |
Low-medium |
Tracheal tubes, Stents |
Class C | Medium-high |
Lung ventilators, Incubators for babies |
Class D | High |
Cardiovascular catheters, Carotid artery shunts |
Registration in Saudi Arabia requires prior approval in one of the following reference markets: Australia, Canada, Europe, Japan, or the USA. Generally, medical device or IVD classification in the reference market will determine how the SFDA classifies the device.
An authorized representative (AR) must be appointed if the manufacturer does not have an office or entity in Saudi Arabia. The AR must have an authorized representative license, which is renewable on an annual basis, to legally represent manufacturers in the KSA.
The KSA Authorized Representative is also responsible for submitting all application documents to the SFDA to register the medical device.
Class A medical device excluding class As, class Am, class Ar can be authorized via medical device listing or medical device marketing authorization.
Documentation and Labeling can be provided in Arabic.
Class B, class C, class D medical device can be authorized via medical device marketing authorization route.
To begin the Saudi medical device registration process, manufacturers must appoint a Local Authorized Representative (LAR) in Saudi Arabia. The Local Authorized Representative (LAR) acts as the official liaison with the SFDA and ensures compliance with all regulatory requirements.
Key responsibilities include:
The LAR must meet these qualifications:
The Authorised Representative must follow the specific requirements listed in the SFDA guidance MDS-REQ 1 Requirements for Medical Device Marketing Authorization in Saudi Arabia.
Classification is a critical step in Saudi medical device registration. Devices are categorized into four risk classes: Class A (low risk), Class B, Class C, and Class D (high risk). The classification depends on:
Consult the SFDA’s Risk Classification Rules for Medical Devices for guidance on the Saudi medical device registration. Accurate classification ensures a streamlined approval process.
Comprehensive technical documentation is essential for SFDA medical device approval. For low-risk devices, the required documentation includes:
High-risk devices may require additional documentation, such as clinical data and detailed testing results. The SFDA reserves the right to request supplementary documents even after approval.
Ensure all documents are complete and accurate when submitting the “Application Form for Medical Devices Marketing Authorization” through the GHAD system to avoid delays.
Medical device registration fees in Saudi Arabia vary based on the classification of the device.
The SFDA may request additional information to ensure the safety and performance of the device. These requests could include:
Inspections of manufacturing sites or product testing may also be required for high-risk devices. Prompt responses to SFDA inquiries are crucial to prevent approval delays.
After completing the review, the SFDA will issue an MDMA certificate in both Arabic and English, which is the SFDA medical device approval. This certificate authorises the marketing of your medical device in Saudi Arabia and includes:
The MDMA certificate is typically valid for one year and can be renewed
Fee Groups | The Basis of the application for SFDA Marketing Authorization | Evaluation Fee | Timeline (Working Days) |
FG (1) |
|
SAR 15000 | 35 |
FG (2) |
|
SAR 19000 | 35 |
FG (3) |
|
SAR 21000 | 35 |
FG (4) |
|
SAR 23000 | 35 |
Source: https://www.sfda.gov.sa/sites/default/files/2024-12/UPDATE-RISK-CLASES_0.pdf
Type of Change request | Fees |
Update in – Adding Device, models, brand name change, change in device design | SAR 5000 |
Update in – IFU, labels or advertising materials | SAR 1100 |
Update in – major change in manufacturer name/address, risk class, jurisdictions, notified body | Full Registration Fee |
Minor change manufacturer address / name | SAR 5000 |
Change Notified Body with a transition period letter | SAR 5000 |
Change notified body due to Brexit (Same NB different number) | SAR 5000 |
MDMA Renewal | SAR 5000 |
Source – https://www.sfda.gov.sa/sites/default/files/2021-01/MDS-01-01-21.pdf
Adverse Event | Timeframe to report |
a serious public health threat | 2 days |
a threat that may cause or contribute, directly or indirectly, in death or serious injury. | 10 days |
any effect other than what is mentioned in the aforementioned items. | 30 days |
When the NCMDR contacts manufacturers, authorized representatives, and healthcare providers for following up the investigation of incident, adverse event, or complaint, they shall response within 5 days |
Investigation | Timeline for submitting Final Report |
occurrence or awareness of adverse events or complaint that does not require testing or technical evaluation | 15 days |
occurrence or awareness of adverse events or complaint that requires testing the device inside KSA. | 30 days |
occurrence or awareness of adverse events or complaint that requires testing the device outside KSA. | 60 days |
Manufacturers and authorized representatives shall report the NCMDR any field safety corrective action (FSCA) or warnings affecting KSA and issued by the manufacturer or similar regulatory authorities outside the Kingdom.
https://www.sfda.gov.sa/sites/default/files/2023-03/(MDS-REQ%2011)E_0.pdf
Before placing a medical device into the Saudi Arabia market.
Contact us for free consultation: info@omcmedical.co.uk
This will close in 0 seconds